[Cardiovascular comorbidity in COPD] (Q82707715)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20116745 AND SRC:MED&resulttype=core&format=json

17 January 2020

review article

1 reference

title

[Cardiovascular comorbidity in COPD] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20116745 AND SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

Juan José Soler Cataluña

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20116745 AND SRC:MED&resulttype=core&format=json

17 January 2020

Miguel Angel Martínez García

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20116745 AND SRC:MED&resulttype=core&format=json

17 January 2020

publication date

1 January 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20116745 AND SRC:MED&resulttype=core&format=json

Archivos de Bronconeumologia

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20116745 AND SRC:MED&resulttype=core&format=json

17 January 2020

volume

45 Suppl 4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20116745 AND SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

18-23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20116745 AND SRC:MED&resulttype=core&format=json

The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature

17 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

Mortality associated with respiratory function and symptoms in advanced age. The Framingham Study

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

Lung function and risk of fatal and non-fatal stroke. The Copenhagen City Heart Study

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

Hospitalizations and mortality in the Lung Health Study

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

Lung function and ischemic stroke incidence: the Atherosclerosis Risk in Communities study

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

[Cardiovascular disease epidemiology and risk factors in primary care]

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

Patterns of comorbidities in newly diagnosed COPD and asthma in primary care

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

Health care utilization in chronic obstructive pulmonary disease. A case-control study in a health maintenance organization

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohort

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

Airflow limitation in smokers is associated with subclinical atherosclerosis.

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

Inflammation and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

Local and systemic inflammation in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

C-reactive protein elevation and disease activity in patients with coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

Cardiovascular injury and repair in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

[Chronic obstructive pulmonary disease and cardiovascular events]

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

Reduced pulmonary function is associated with central arterial stiffness in men

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

Arterial Stiffness and Osteoporosis in Chronic Obstructive Pulmonary Disease

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

Increased arterial stiffness in patients with chronic obstructive pulmonary disease: a mechanism for increased cardiovascular risk

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

Impaired flow-mediated dilation is associated with low pulmonary function and emphysema in ex-smokers: the Emphysema and Cancer Action Project (EMCAP) Study

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

Possible effects of vascular endothelial growth factor in the pathogenesis of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

Determinants of systemic vascular function in patients with stable chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

Telomeres and telomerase

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

Telomere shortening in smokers with and without COPD

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

Alveolar cell senescence in patients with pulmonary emphysema

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

Age dependent aneuploidy and telomere length of the human vascular endothelium

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

Association of left-heart dysfunction with severe exacerbation of chronic obstructive pulmonary disease: diagnostic performance of cardiac biomarkers

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

Use of B-Type Natriuretic Peptide in the Risk Stratification of Acute Exacerbations of COPD

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

Differential diagnosis of elevated troponins

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

Effect of chronic obstructive pulmonary disease on survival of patients with coronary heart disease having percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

Mortality in COPD: Role of comorbidities.

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

EPOC en la vida y en la muerte

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

Factors affecting survival of hospitalised patients with COPD.

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

Statin use is associated with reduced mortality in COPD.

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

Statin use reduces decline in lung function: VA Normative Aging Study

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

Impact of cardioselective beta-blockers on mortality in patients with chronic obstructive pulmonary disease and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

Low-dose inhaled corticosteroids and the risk of acute myocardial infarction in COPD

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

Possible protection by inhaled budesonide against ischaemic cardiac events in mild COPD.

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

A 4-year trial of tiotropium in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

Effects of hyperinflation on the oxygen pulse as a marker of cardiac performance in COPD.

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

Effects of Lung Volume Reduction Surgery on Left Ventricular Diastolic Filling and Dimensions in Patients With Severe Emphysema *

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(09)72859-5

7 January 2021

10.1016/S0300-2896(09)72859-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20116745 AND SRC:MED&resulttype=core&format=json

17 January 2020

1 reference